Results 91 to 100 of about 6,659 (141)

Effects of fibrinogen receptor antagonist GR144053F and aurintricarboxylic acid on platelet activation and degranulation11Abbreviations: ACD, citric acid/trisodium citrate/glucose (recipe A), blood anticoagulant; ATA, aurintricarboxylic acid; CTCADP, closure (occlusion) time determined with the use of collagen/ADP cassettes in PFA-100; GPIb-IX-V, a complex of glycoproteins Ib, IX, and V, a vWF receptor; GPIIb-IIIa, a complex of glycoproteins IIb and IIIa, a fibrinogen receptor; ic50, the …

open access: closedBiochemical Pharmacology, 2001
Activated blood platelets play crucial role in restenosis due to their fundamental significance in thrombus formation. Therefore, platelets are attractive targets for the inhibition with a variety of antagonists. In this study, we present direct evidence that GR144053F [non-peptide antagonist of glycoprotein IIb-IIIa complex (GPIIb-IIIa)] inhibits ...
M. Różalski   +3 more
openalex   +4 more sources
Some of the next articles are maybe not open access.

Related searches:

Alteration in GPIIb/IIIa Binding of VWD-Associated von Willebrand Factor Variants with C-Terminal Missense Mutations

Thrombosis and Haemostasis, 2019
The platelet receptor glycoprotein (GP) IIb/IIIa, formed by integrins αIIb and β3, plays an important role in platelet adhesion and aggregation. Its major binding site is the arginine-glycine-aspartic acid (RGD) sequence present in several adhesive ...
G. König   +6 more
semanticscholar   +1 more source

Identification of Clinicopathological Spectrum, Platelet Glycoprotein IIb/IIIa complex and Platelet Antibodies in Egyptian Children with Glanzmann’s Thrombasthenia

Archivum Immunologiae et Therapiae Experimentalis, 2017
Asmaa M. Zahran   +4 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy